Menu
Recruiting NCT05492422

Central Executive Training and Parent Training for ADHD

No phase Interventional ADHD

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Central Executive Training (CET), Behavioral Parent Training (BPT).
Who it may be relevant to
Registry conditions: ADHD. Basic parameters: 8 years — 12 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Evaluating the Efficacy of Sequenced Central Executive and Behavioral Parent Training for Children With ADHD

Overview

The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities. BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors. Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.

Interventions

  • Device Central Executive Training (CET)
    Central Executive Training (CET)
  • Behavioral Behavioral Parent Training (BPT)
    Behavioral Parent Training (BPT)

Primary outcome measures

  • Rapport visuospatial/phonological working memory test [Time frame: Administered during a 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]
  • Alabama parenting scale [Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]
  • Parenting sense of competence scale [Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]
  • Parent stress index [Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]
Secondary outcome measures (3)
  • Behavior Assessment System for Children [Time frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]
  • ADHD Rating Scale [Time frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]
  • ODD symptoms (DSM-based checklist) [Time frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session]

Eligibility criteria

Inclusion:

  • Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and
  • parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants).

All DSM-5 ADHD presentations will be eligible.

Exclusion:

  • gross neurological, sensory, or motor impairment;
  • history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use);
  • intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score <70;
  • conditions requiring acute intervention, e.g., active suicidality; and
  • non-English speaking child or parent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Triple blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Florida State University — Tallahassee

Identifiers

NCT: NCT05492422 · 1R01MH125893

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗